Renaissance Technologies »

Celldex Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 195k 25.87
2025-06-30 $3.7M 181k 20.35
2025-03-31 $2.7M 147k 18.15
2024-12-31 $3.5M 137k 25.27
2024-06-30 $1.6M 43k 37.01
2024-03-31 $13M 313k 41.97
2022-09-30 $728k 26k 28.12
2021-09-30 $8.7M 161k 53.99
2021-06-30 $12M 364k 33.44
2021-03-31 $11M 541k 20.60
2020-12-31 $18M 1.0M 17.52
2020-09-30 $26M 1.7M 14.83
2020-06-30 $21M 1.6M 13.00
2020-03-31 $1.9M 1.2M 1.66
2019-12-31 $2.5M 1.1M 2.23
2019-09-30 $2.2M 1.0M 2.13
2019-06-30 $2.4M 912k 2.68
2019-03-31 $2.7M 545k 4.92